{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:33:26Z","timestamp":1747172006594,"version":"3.40.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.urology.2017.04.053","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T19:00:51Z","timestamp":1499713251000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Secular Trends in Prostate Biopsy Criteria and Outcomes: The Dartmouth Experience"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-8837","authenticated-orcid":false,"given":"Lael","family":"Reinstatler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody","family":"Rissman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Seigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias S.","family":"Hyams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.04.053_bib0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2017.04.053_bib0015","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1001\/jama.2015.14905","article-title":"Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations","volume":"314","author":"Jemal","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2017.04.053_bib0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jamaoncol.2016.2667","article-title":"Prostate cancer incidence rates 2 years after the US Preventive Services Task Force recommendations against screening","volume":"2","author":"Jemal","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urology.2017.04.053_bib0025","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2015.06.075","article-title":"Effect of the USPSTF grade D recommendation against screening for prostate cancer on incident prostate cancer diagnoses in the United States","volume":"194","author":"Barocas","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.04.053_bib0030","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.juro.2013.12.010","article-title":"The impact of recent screening recommendations on prostate cancer screening in a large health care system","volume":"191","author":"Aslani","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.04.053_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2013.04.013","article-title":"Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation","volume":"32","author":"Cohn","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2017.04.053_bib0040","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.juro.2014.11.096","article-title":"Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates","volume":"193","author":"Bhindi","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.04.053_bib0045","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.2015.7273","article-title":"Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations","volume":"314","author":"Sammon","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2017.04.053_bib0050","first-page":"825","article-title":"Early-stage prostate cancer, PSA screening rates decline","volume":"122","author":"Printz","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2017.04.053_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ypmed.2015.11.017","article-title":"Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre\/post 2012","volume":"82","author":"Rezaee","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.urology.2017.04.053_bib0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.juro.2015.07.099","article-title":"Prostate needle biopsy outcomes in the era of the U.S. Preventive Services Task Force recommendation against prostate specific antigen based screening","volume":"195","author":"Banerji","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.04.053_bib0065","series-title":"A Dartmouth Atlas of Health Care Series","article-title":"Variation in the care of surgical conditions: prostate cancer","author":"Hyams","year":"2016"},{"key":"10.1016\/j.urology.2017.04.053_bib0070","series-title":"A Dartmouth Atlas of Health Care Series","article-title":"Regional rates of prostate cancer screening vary by a factor of fifteen","author":"Hyams","year":"2014"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517306015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517306015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T06:52:48Z","timestamp":1535611968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429517306015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":13,"alternative-id":["S0090429517306015"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.04.053","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secular Trends in Prostate Biopsy Criteria and Outcomes: The Dartmouth Experience","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}